+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 847949-49-9
847949-49-9,MFCD09952182
Catalog No.:AA004OH9

847949-49-9 | 4-((3-Chloro-4-fluorophenyl)amino)-6-(3-morpholinopropoxy)quinazolin-7-ol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$70.00   $49.00
- +
5mg
≥95%
in stock  
$229.00   $160.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA004OH9
Chemical Name:
4-((3-Chloro-4-fluorophenyl)amino)-6-(3-morpholinopropoxy)quinazolin-7-ol
CAS Number:
847949-49-9
Molecular Formula:
C21H22ClFN4O3
Molecular Weight:
432.8758
MDL Number:
MFCD09952182
SMILES:
Oc1cc2ncnc(c2cc1OCCCN1CCOCC1)Nc1ccc(c(c1)Cl)F
Properties
Properties
 
Form:
Solid  
MP:
115-120°C  
Storage:
-20 ℃;Keep in dry area;  

Computed Properties
 
Complexity:
531  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
7  
XLogP3:
3.8  

Downstream Synthesis Route

[1]TetrahedronLetters,2005,vol.46,p.7381-7384

[2]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4102-4106

[3]Patent:WO2017/201069,2017,A1.Locationinpatent:Paragraph0527

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4102-4106

[1]Wang,Ji-Quan;Gao,Mingzhang;Miller,KathyD.;Sledge,GeorgeW.;Zheng,Qi-Huang[BioorganicandMedicinalChemistryLetters,2006,vol.16,#15,p.4102-4106]

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4102-4106

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4102-4106

Literature

Title: Kobayashi H, et al. Effects of polymorphisms in CYP2D6 and ABC transporters and side effects induced by gefitinib on the pharmacokinetics of the gefitinib metabolite, O-desmethyl gefitinib. Med Oncol. 2016 Jun;33(6):57.

Title: McKillop D, et al. Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition. Xenobiotica. 2006 Jan;36(1):29-39.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 847949-49-9
184475-35-2

184475-35-2

 1603814-04-5

1603814-04-5

 847949-51-3

847949-51-3

 912556-91-3

912556-91-3

 184475-55-6

184475-55-6

 1228664-49-0

1228664-49-0
Building Blocks
More >
Tags:847949-49-9 Molecular Formula|847949-49-9 MDL|847949-49-9 SMILES|847949-49-9 4-((3-Chloro-4-fluorophenyl)amino)-6-(3-morpholinopropoxy)quinazolin-7-ol